Cargando…
Targeting Inflammation is a Double-Edged Sword. Is PDIA1 A Key?
Autor principal: | Shimosawa, Tatsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444801/ https://www.ncbi.nlm.nih.gov/pubmed/35135931 http://dx.doi.org/10.5551/jat.ED191 |
Ejemplares similares
-
ATP, a double-edged sword in cancer
por: Jiang, Jean X., et al.
Publicado: (2015) -
Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
por: Lipworth, Brian, et al.
Publicado: (2021) -
PPARs: A Double-Edged Sword in Cancer Therapy?
por: Panigrahy, Dipak, et al.
Publicado: (2008) -
Microglia in Health and Disease: A Double-Edged Sword
por: Santiago, Ana Raquel, et al.
Publicado: (2017) -
Hepatic ductular reaction: a double-edged sword
por: Sun, Tianliang, et al.
Publicado: (2019)